ALX-210-764-C100
antibody from Enzo Life Sciences
Targeting: CCR8
CDw198, CKR-L1, CMKBR8, CMKBRL2, CY6, GPR-CY6, TER1
Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ALX-210-764-C100 - Provider product page
- Provider
- Enzo Life Sciences
- Proper citation
- Enzo Life Sciences Cat#ALX-210-764-C100, RRID:AB_2050998
- Product name
- CCR8 (human) polyclonal antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Epitope-affinity purified IgG.
- Reactivity
- Human
- Host
- Goat
- Vial size
- 100 μg
- Storage
- -20°C
- Handling
- For maximum product recovery after thawing, centrifuge the vial before opening the cap. Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20¡C.
Submitted references Possible link between unique chemokine and homing receptor expression at diagnosis and relapse location in a patient with childhood T-ALL.
Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes.
The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium.
CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells.
The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains.
Molecular cloning and chromosomal mapping of a novel human gene, ChemR1, expressed in T lymphocytes and polymorphonuclear cells and encoding a putative chemokine receptor.
Annels NE, Willemze AJ, van der Velden VH, Faaij CM, van Wering E, Sie-Go DM, Egeler RM, van Tol MJ, Révész T
Blood 2004 Apr 1;103(7):2806-8
Blood 2004 Apr 1;103(7):2806-8
Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes.
Annunziato F, Cosmi L, Liotta F, Lazzeri E, Manetti R, Vanini V, Romagnani P, Maggi E, Romagnani S
The Journal of experimental medicine 2002 Aug 5;196(3):379-87
The Journal of experimental medicine 2002 Aug 5;196(3):379-87
The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium.
Haque NS, Fallon JT, Taubman MB, Harpel PC
Blood 2001 Jan 1;97(1):39-45
Blood 2001 Jan 1;97(1):39-45
CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells.
Haque NS, Zhang X, French DL, Li J, Poon M, Fallon JT, Gabel BR, Taubman MB, Koschinsky M, Harpel PC
Circulation 2000 Aug 15;102(7):786-92
Circulation 2000 Aug 15;102(7):786-92
The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains.
Horuk R, Hesselgesser J, Zhou Y, Faulds D, Halks-Miller M, Harvey S, Taub D, Samson M, Parmentier M, Rucker J, Doranz BJ, Doms RW
The Journal of biological chemistry 1998 Jan 2;273(1):386-91
The Journal of biological chemistry 1998 Jan 2;273(1):386-91
Molecular cloning and chromosomal mapping of a novel human gene, ChemR1, expressed in T lymphocytes and polymorphonuclear cells and encoding a putative chemokine receptor.
Samson M, Stordeur P, Labbé O, Soularue P, Vassart G, Parmentier M
European journal of immunology 1996 Dec;26(12):3021-8
European journal of immunology 1996 Dec;26(12):3021-8
No comments: Submit comment
No validations: Submit validation data